DXB 3.92% 53.0¢ dimerix limited

Ann: Dimerix Completes $20M Placement, page-88

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    So? This has nothing to do with that.
    —-what I’m referring to is where in the treatment guidelines or practices this dimx drug will fit because there are a number of immunological drugs already used first line (check this out
    https://kdigo.org/wp-content/uploads/2022/12/How-I-Treat-FSGS.pdf

    —- this dimx drug looks a comparatively weaker immunological drug compared with the powerful drugs already used, I don’t see it replacing established things referenced in the article like steroids or calcineurim inhib, rituximab.
    —— dimx drug looks like it’s v safe, but lack of side effects is probably an indication of its weaker immunological ability.
    —-/ looks more like a back up reserve drug to use once you’ve exhausted other things
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
53.0¢
Change
0.020(3.92%)
Mkt cap ! $291.6M
Open High Low Value Volume
51.0¢ 53.8¢ 51.0¢ $782.0K 1.490M

Buyers (Bids)

No. Vol. Price($)
1 6408 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.5¢ 35657 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.